|
 |
 |
| March 23, 2011 |
| Recalled Drug Sibutramine in Slimming Beauty Bitter Orange Slimming Capsules |
| Posted By DeCarli Law |
 |
The FDA has announced that Slimming Beauty Bitter Orange Slimming Capsules contain Sibutramine, a stimulant recently recalled by the FDA and previously only available by prescription.
Sibutramine is not listed on the product label as an ingredient.
Because it contains Sibutramine, Slimming Beauty poses a particularly heightened risk for people with cardiovascular conditions because it can lead to elevated blood pressure, stroke, and heart attack. However, even people who are otherwise healthy who take Slimming Beauty can experience anxiety, nausea, heart palpitations, a racing heart, insomnia, and elevated blood pressure, given the amount of
Sibutramine it contains. The
Sibutramine in Slimming Beauty also may interact with other medications and can cause serious side effects.
You should stop taking Slimming Beauty immediately. If you believe you believe you have suffered a side effect or adverse reaction from Slimming Beauty, you should report it to the FDA. You may do so online HERE
. Also, save the product packaging, as it may help your ability to make a legal claim if you desire to do so. |
|
| Continue reading "Recalled Drug Sibutramine in Slimming Beauty Bitter Orange Slimming Capsules" » |
|
Permalink  |
| |
| March 21, 2011 |
| Undeclared Drug Ingredient Leads to Recall of Joyful Slim Herb Supplement |
| Posted By DeCarli Law |
|
FDA lab analysis in mid-2010 found that Joyful Slim Herb Supplement, an over-the-counter diet supplement, contained an undeclared drug, desmethyl sibutramine. This finding has renewed importance now, because Sibutramine has since been recalled from the market because it substantially increases blood pressure and/or pulse rate among some patients, and may present a significant risk for patients with coronary artery disease, congestive heart failure, arrhythmias or stroke.
Joyful Slim Herb was marketed as a natural herb for weight loss, and was packaged in plastic bottles containing 30 capsules per bottle with UPC 8 97966 00200 7. The affected lot/code being recalled is 101408.
Consumers should not use the affected lot/code. If you believe you believe you have suffered a side effect or adverse reaction from using this product, you should report it to the FDA. You may do so online HERE
. Also, save the product packaging, as it may help your ability to make a legal claim if you desire to do so. |
|
| Continue reading "Undeclared Drug Ingredient Leads to Recall of Joyful Slim Herb Supplement" » |
|
| Permalink |
| |
| March 18, 2011 |
| Slim-30 Weight Loss Drug Recall Update |
| Posted By DeCarli Law |
|
Slim-30 Herb Supplement was recalled in mid-2010 because it contained undeclared drug ingredients. This recall now has heightened importance because one of those drugs, Sibutramine, has now itself been recalled.
FDA lab analysis of Slim-30 Herb Supplement in July 2010 revealed that it contained N-Desmethyl Sibutramine and traces of Sibutramine. Since then, Sibutramine has been recalled by the FDA.
Sibutramine was previously used as an appetite suppressant for weight loss, but available only by prescription. Slim-30 posed a threat to consumers because
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Slim-30 Herb Supplement was marketed as a Natural Herb for Weight Loss. Slim-30 Herb Supplement is packaged in plastic bottles containing 30 capsules per bottle and bears UPC 8 31457 005009 2. The affected lot/codes recalled are 032009 and 6032101. The product was sold to distributors and retail stores nationwide and China and via internet sales.
Consumers should immediately stop using Slim-30. If you believe you have experienced any side effects from Slim-30, you should report them to the FDA. You may do so online HERE. Also, save the product packaging, as it may help your ability to make a legal claim if you desire to do so. |
|
| Continue reading "Slim-30 Weight Loss Drug Recall Update" » |
|
| Permalink |
| |
| March 16, 2011 |
| Weight Loss Product Fruta Planta Contains Recalled Drug Sibutramine |
| Posted By DeCarli Law |
|
The FDA has received multiple reports of adverse events from the use of Fruta Planta, including several cardiac events and one death. FDA laboratory analysis confirmed that Fruta Planta contains Sibutramine, a controlled substance that was withdrawn from the market in October 2010.
Fruta Planta was promoted and sold on various websites as a dietary supplement for weight loss. The product poses a threat to consumers because Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Fruta Planta may also interact in life threatening ways with other medications a consumer may be taking.
Consumers should stop using Fruta Planta immediately. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible. Consumers also should report negative side effects to the FDA. You may do so online HERE. Also, save the product packaging, as it may help your ability to make a legal claim if you desire to do so. |
|
| Continue reading "Weight Loss Product Fruta Planta Contains Recalled Drug Sibutramine" » |
|
| Permalink |
| |
| March 15, 2011 |
| FDA Warns Que She Herbal Supplement Contains Undisclosed and Recalled Drugs |
| Posted By DeCarli Law |
|
In mid-2010, the FDA warned consumers and healthcare professionals that Que She contained multiple undisclosed drug ingredients. This warning has renewed importance now because one of those drugs, Sibutramine, has since been recalled from the market.
The FDA initially warned that Que She, marketed as an herbal weight loss supplement, contains unlisted and active pharmaceutical ingredients that could harm consumers, especially those with cardiovascular conditions. These active pharmaceutical ingredients also may interact with other medications and result in a serious adverse event.
FDA analysis of Que She found that it contains:
- Fenfluramine – a stimulant drug withdrawn from the U.S. market in 1997 after studies demonstrated that it caused serious heart valve damage.
- Propranolol – a prescription beta blocker drug that can pose a risk to people with bronchial asthma and certain heart conditions.
-
Sibutramine – a weight loss drug recalled from the market in October 2010.
Sibutramine was the subject of a recent study whose preliminary findings showed an association between sibutramine use and increased risk of heart attack and stroke in patients who have a history of heart disease
- Ephedrine – a stimulant drug that is legally marketed over-the-counter for temporary relief of asthma but can pose a risk to people with certain cardiovascular conditions.
Que She, advertised as “Slimming Factor Capsule” and as “an all-natural blend of Chinese herbs,” has been widely distributed on Internet sites such as the Bouncing Bear Botanicals website, and at retail outlets, including Sacred Journey in Lawrence, Kansas. People who purchased Que She should stop taking the product immediately and consult a health care professional.
If you believe you have suffered a side effect or adverse reaction from using this product, you should report it to the FDA. You may do so online HERE. Also, save the product packaging, as it may help your ability to make a legal claim if you desire to do so. |
|
| Continue reading "FDA Warns Que She Herbal Supplement Contains Undisclosed and Recalled Drugs" » |
|
| Permalink |
| |
| March 11, 2011 |
| Celerite Slimming Capsules Recalled Because They Contain the Recalled Drug Sibutramine |
| Posted By DeCarli Law |
|
FDA laboratory analysis confirmed that Celerite Slimming Capsules contain Sibutramine, a controlled substance that was withdrawn from the market in October 2010 for safety reasons.
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and presents a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact in life threatening ways with other medications a consumer may be taking.
Celerite Slimming Capsules, marketed as a dietary supplement for weight loss, is sold on various websites. Claims made for the product falsely state that it is “safe” and an “all-natural herbal weight loss remedy.”
Consumers should stop using Celerite Slimming Capsules. If you believe you have suffered a side effect or adverse reaction from using this product, you should report it to the FDA. You may do so online HERE. Also, save the product packaging, as it may help your ability to make a legal claim if you desire to do so. |
|
| Continue reading "Celerite Slimming Capsules Recalled Because They Contain the Recalled Drug Sibutramine" » |
|
| Permalink |
| |
| March 10, 2011 |
| Svelte 30 Weight Loss Product Recalled, Contains Banned Drug Sibutramine |
| Posted By DeCarli Law |
|
FDA lab analysis of Svelte 30 revealed that it contains Sibutramine, once a prescription-only appetite suppressant that has now been withdrawn from the market. Svelte 30 may pose a threat to consumers because
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and presents a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Svelte 30 orange & gray capsules are marketed as a natural herb for weight loss. Svelte 30 Herb Supplement is packaged in plastic bottles containing 30 capsules per bottle and bears UPC #s from 04-3000 to 04-5999. They bear the manufacture date of 10/22/2010, with an expiration date of 10/21/2012.
Consumers should stop using the affected lots of Svelte 30 immediately. If you believe you have suffered a side effect or adverse reaction from using this product, you should report it to the FDA. You may do so online HERE. Also, save the product packaging, as it may help your ability to make a legal claim if you desire to do so.
|
|
| Continue reading "Svelte 30 Weight Loss Product Recalled, Contains Banned Drug Sibutramine" » |
|
| Permalink |
| |
| March 09, 2011 |
| Meridia (Sibutramine) Withdrawn From Market Because of Heart Attack and Stroke Risk |
| Posted By DeCarli Law |
|
Abbott Laboratories and the FDA reported that the obesity drug Meridia, generic name
Sibutramine, has been voluntarily withdrawn from the market. Clinical trial data indicates the use of
Meridia/Sibutramine increases the risk of heart attack and stroke.
The FDA requested that Meridia be withdrawn from the market after reviewing data from the Sibutramine Cardiovascular Outcomes Trial. The clinical trial was part of a postmarket requirement to look at cardiovascular safety of Sibutramine after its initial approval in Europe. The trial found a 16-percent increase in the risk of serious heart events, including non-fatal heart attack, non-fatal stroke, the need to be resuscitated once the heart stopped, and even death, in a group of patients given Sibutramine, compared with those given only a placebo. There also was only a small difference in weight loss between the placebo group and the group that received Sibutramine.
Physicians have been advised to stop prescribing Meridia, and patients should stop taking any Meridia/Sibutramine previously prescribed to them. If you believe you have suffered a side effect or adverse reaction from
Meridia/Sibutramine, you should report it to the FDA. You may do so online
HERE.
|
|
| Continue reading "Meridia (Sibutramine) Withdrawn From Market Because of Heart Attack and Stroke Risk" » |
|
| Permalink |
| | |
|
 |